Parkinson’s UK invests further £490K in NRG Therapeutics Parkinson’s Drug Discovery Programme
Cambridge, UK, 23 August 2021 - NRG Therapeutics Ltd (“NRG” or “company”), an innovative neuroscience company targeting mitochondrial...
NRG Therapeutics Awarded $500K Grant from The Michael J. Fox Foundation
Wednesday 29 July 2021 - NRG Therapeutics Ltd (“NRG” or “company”), an innovative neuroscience company targeting mitochondrial...
Parkinson’s UK Implements CDD Vault to Manage Its Pioneering Drug Discovery Data
London and San Francisco, July 19, 2021 - Parkinson’s UK, the largest charitable funder of Parkinson’s research in Europe, has announced...
UK charity announces £1.2 million funding to design Parkinson’s drug
Tuesday 09 March 2021 - Parkinson’s UK, the largest charitable funder of Parkinson’s research in Europe, is investing up to £1.2 million...
New biotech to drive forward research into potentially life changing Parkinson’s treatment
Parkinson’s UK to create a company dedicated to pushing forward an experimental treatment with potential to stop or reverse Parkinson’s...
Global charities join forces to drive forward new drug for Parkinson’s
Monday 23 November 2020 - Leading charities Parkinson’s UK and The Michael J. Fox Foundation for Parkinson’s Research have joined forces...